다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Digestion, v.95 no.1, 2017년, pp.49 - 54
Suzuki, Takayoshi , Masui, Aya , Nakamura, Jun , Shiozawa, Hirokazu , Aoki, Jun , Nakae, Hirohiko , Tsuda, Shingo , Imai, Jin , Hideki, Ozawa , Matsushima, Masashi , Mine, Tetsuya , Tamura, Akira , Ohtsu, Toshihiro , Asami, Yukio , Takagi, Atsushi
AI-Helper
Background: Although there is evidence about the beneficial effects of probiotics, their effects on aspirin-induced small bowel injuries have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri OLL2716 (LG) on aspirin-induced small intestinal lesions, such as ulce...
1 Awtry EH, Loscalzo J: Aspirin. Circulation 2000;101:1206-1218.
2 Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, et al: Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310:827-830.
3 Satoh K, Yoshino J, Akamatsu T, Itoh T, Kato M, Kamada T, et al: Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol 2016;51:177-194.
4 Targownik LE, Metge CJ, Leung S, Chateau DG: The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology 2008;134:937-944.
5 Takeuchi K, Satoh H: NSAID-induced small intestinal damage - roles of various pathogenic factors. Digestion 2015;91:218-232.
6 Endo H, Sakai E, Kato T, Umezawa S, Higurashi T, Ohkubo H, et al: Small bowel injury in low-dose aspirin users. J Gastroenterol 2015;50:378-386.
7 Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013;19:576-585.
8 Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al: Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 2015;67:128-139.
9 Sun J, Furio L, Mecheri R, van der Does AM, Lundeberg E, Saveanu L, et al: Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 2015;43:304-317.
10 Cox A, West NP, Cripps AW: Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol 2015;3:207-215.
11 Szajewska H, Shorka A, Ruszcznski M, Gieruszczak-Bialek D: Meta-analysis: lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007;25:871-881.
12 Ooi LG, Liong MT: Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci 2010;11:2499-2522.
13 Guo Z, Liu XM, Zhang QX, Shen Z, Tian FW, Zhang H, et al: Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 2011;21:844-850.
14 Endo H, Higurashi T, Hosono K, Sakai E, Sekino Y, Iida H, et al: Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol 2011;46:894-905.
15 Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al: Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 2004;39:888-891.
16 Svedlund J, Sjodin I, Dotevall G: GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-134.
17 Watanabe T, Takeuchi T, Handa O, Sakata Y, Tanigawa T, Shiba M, et al: A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage. PLoS One 2015;10:e0122330.
18 Endo H, Hosano K, Inamori M, Nozaki Y, Yoneda K, Fujita K, et al: Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol 2009;44:544-549.
19 Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, et al: Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008;6:1279-1282.
20 Mizukami K, Murakami K, Abe T, Inoue K, Uchida M, Okimoto T, et al: Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol 2011;46:5117-5122.
21 Fujimori S, Takahashi Y, Gudis K, Seo T, Ehara A, Kobayashi T, et al: Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy. J Gastroenterol 2011;46:57-64.
22 Kurokawa S, Katsuki S, Fujita T, Saitoh Y, Ohta H, Nishikawa K, et al: A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury. J Gastroenterol 2014;49:239-244.
23 Lai Y, Zhong W, Yu T, Xia ZS, Li JY, Ouyang H, et al: Rebamipide promotes the regeneration of aspirin-induced small-intestine mucosal injury through accumulation of β-Catenin. PLoS One 2015;10:e0132031.
24 Watari I, Oka S, Tanaka S, Aoyama T, Imagawa H, Shishido T, et al: Effectiveness of Polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled study. BMC Gastroenterol 2013;13:108.
25 Kawano M, Miyoshi M, Ogawa A, Sakai F, Kadooka Y: Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet. J Nutr Sci 2016;5:e23.
26 Emara MH, Mohamed SY , Abdel-Aziz HR: Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial. Therap Adv Gastroenterol 2014;7:4-13.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.